Serum IgG: A potential biomarker for predicting the efficacy of systemic therapy in metastatic renal cell carcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary Cancers Symposium ...
This is due to epigenetic components: microRNA, histone and DNA methylation, gene mutations that alter the expression and production of the neurotrophic factor BDNF, which interacts with the receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results